Guangcheng Dai

503 total citations
31 papers, 376 citations indexed

About

Guangcheng Dai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Guangcheng Dai has authored 31 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Guangcheng Dai's work include Prostate Cancer Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (5 papers) and Circular RNAs in diseases (5 papers). Guangcheng Dai is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (5 papers) and Circular RNAs in diseases (5 papers). Guangcheng Dai collaborates with scholars based in China and United States. Guangcheng Dai's co-authors include Boxin Xue, Feng Yuan, Jinhui Yang, Jin Zhu, Lü Jin, Xiang Han, Jian Tu, Kai Fu, Peng Pan and Chaogang Wei and has published in prestigious journals such as Frontiers in Immunology, American Journal of Roentgenology and Food and Chemical Toxicology.

In The Last Decade

Guangcheng Dai

30 papers receiving 368 citations

Peers

Guangcheng Dai
Bogdan Petruţ Romania
Jindong Sheng China
Hideki Mukouyama Japan
Yuanjie Niu China
Xiangming Mao China
Liangren Liu China
Jian Gu China
Xiangkun Wu China
Frances M. Martin United States
Bogdan Petruţ Romania
Guangcheng Dai
Citations per year, relative to Guangcheng Dai Guangcheng Dai (= 1×) peers Bogdan Petruţ

Countries citing papers authored by Guangcheng Dai

Since Specialization
Citations

This map shows the geographic impact of Guangcheng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangcheng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangcheng Dai more than expected).

Fields of papers citing papers by Guangcheng Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangcheng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangcheng Dai. The network helps show where Guangcheng Dai may publish in the future.

Co-authorship network of co-authors of Guangcheng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Guangcheng Dai. A scholar is included among the top collaborators of Guangcheng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangcheng Dai. Guangcheng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Banglei, et al.. (2025). High-precision visual navigation device calibration method based on collimator. Optics & Laser Technology. 190. 113170–113170. 1 indexed citations
2.
Jin, Zhi‐Cheng, et al.. (2024). Comparison in prostate cancer diagnosis with PSA 4–10 ng/mL: radiomics-based model VS. PI-RADS v2.1. BMC Urology. 24(1). 233–233. 1 indexed citations
3.
Zhu, Jianbing, Guangcheng Dai, Ting Chen, et al.. (2024). Ailanthone suppresses cell proliferation of renal cell carcinoma partially via inhibition of EZH2. Discover Oncology. 15(1). 464–464. 1 indexed citations
4.
Lu, Jin, et al.. (2024). The clinical significance and anti-tumor role of PRKG1 in bladder cancer. Frontiers in Immunology. 15. 1442555–1442555. 3 indexed citations
5.
Dai, Guangcheng, et al.. (2024). Chronic oral administration of L-carnitine induces testicular injury: in vivo evidence. International Urology and Nephrology. 57(1). 35–47. 3 indexed citations
6.
7.
Yin, Xiaoyu, et al.. (2023). Exosomal miR-93-5p as an important driver of bladder cancer progression. Translational Andrology and Urology. 12(2). 286–299. 16 indexed citations
8.
Yang, Jinhui, Bo Tan, Guangcheng Dai, et al.. (2022). circSPECC1 promotes bladder cancer progression via regulating miR-136–5p/GNAS axis. Pathology - Research and Practice. 234. 153914–153914. 7 indexed citations
9.
Wei, Chaogang, Peng Pan, Tong Chen, et al.. (2021). A nomogram based on PI-RADS v2.1 and clinical indicators for predicting clinically significant prostate cancer in the transition zone. Translational Andrology and Urology. 10(6). 2435–2446. 11 indexed citations
10.
Yu, Keqin, Maomao Liu, Yasheng Huang, et al.. (2021). circMBOAT2 serves as the sponge of miR-433-3p to promote the progression of bladder cancer. Pathology - Research and Practice. 227. 153613–153613. 9 indexed citations
11.
Zhou, Yibin, Guangqiang Chen, Guangcheng Dai, et al.. (2021). EZH2-TROAP Pathway Promotes Prostate Cancer Progression Via TWIST Signals. Frontiers in Oncology. 10. 592239–592239. 11 indexed citations
12.
Wei, Chaogang, Tong Chen, Yueyue Zhang, et al.. (2020). Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with “gray zone” PSA levels. European Journal of Radiology. 127. 108977–108977. 15 indexed citations
13.
Xu, Ming, Lijun Xu, Yin Wang, et al.. (2020). BRD4 inhibition sensitizes renal cell carcinoma cells to the PI3K/mTOR dual inhibitor VS-5584. Aging. 12(19). 19147–19158. 9 indexed citations
14.
Dai, Guangcheng, et al.. (2020). A 90‐Day Oral Toxicity Study of the Ethanol Extract from Eupatorium japonicum Thunb and Foeniculum vulgare in Rats. BioMed Research International. 2020(1). 6859374–6859374. 6 indexed citations
15.
Jin, Lu, Feng Yuan, Guangcheng Dai, et al.. (2020). Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells. Cellular & Molecular Biology Letters. 25(1). 17–17. 41 indexed citations
16.
Dai, Guangcheng, et al.. (2020). <p>Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients</p>. OncoTargets and Therapy. Volume 13. 945–958. 11 indexed citations
17.
Jin, Lü, et al.. (2020). Evaluation of clinical effects of microsurgical subinguinal varicocelectomy with and without testicular delivery. Andrologia. 52(6). e13605–e13605. 3 indexed citations
18.
19.
Dai, Guangcheng, Bin Hu, Peng Fang, et al.. (2016). Chemical characterization, anti-benign prostatic hyperplasia effect and subchronic toxicity study of total flavonoid extract of Pteris multifida. Food and Chemical Toxicology. 108(Pt B). 524–531. 13 indexed citations
20.
Dai, Guangcheng, et al.. (2013). Intervention effect and mechanism research of total flavonoid of Pteris multifida in benign prostatic hyperplasia rats. Zhonghua shiyan waike zazhi. 30(12). 2506–2508. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bogdan Petruţ Breakdown of academic impact, for papers by Jindong Sheng Breakdown of academic impact, for papers by Hideki Mukouyama Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Xiangming Mao Breakdown of academic impact, for papers by Liangren Liu Breakdown of academic impact, for papers by Jian Gu Breakdown of academic impact, for papers by Xiangkun Wu Breakdown of academic impact, for papers by Frances M. Martin
Rankless by CCL
2026